SFRP4 and leiomyoma: Evaluation of genomic DNA immunoprecipitated by a high-fidelity antibody specific to the PR demonstrated clear enrichment for sFRP4 promoter in specimens of both myometrium and leiomyoma as compared with control input DNA precipitated with nonspecific immunoglobulins (Supplemental Fig. 5).